Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doriano Fabbro

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Chimia|October 29, 2020
Notch Inhibition in Cancer: Challenges and OpportunitiesDoriano Fabbro, Michael Bauer, Maximilien Murone, et al.
Current Opinion in Cell Biology|February 12, 2009
Structural biology contributions to tyrosine kinase drug discoverySandra W Cowan-Jacob, Henrik Möbitz, Doriano Fabbro
British Journal of Pharmacology|January 30, 2015
Ten things you should know about protein kinases: IUPHAR Review 14Doriano Fabbro, Sandra W Cowan-Jacob, Henrik Moebitz
Plos One|July 5, 2012
Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesisNataliya Kotelevets, Doriano Fabbro, Andrea Huwiler, et al.
International Journal of Molecular Sciences|February 25, 2023
Lipids as Targets for Renal Cell Carcinoma TherapyBisera Stepanovska Tanturovska, Roxana Manaila, Doriano Fabbro, et al.
The Journal of Biological Chemistry|October 3, 2002
Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase CRochus Franzen, Doriano Fabbro, Armaz Aschrafi, et al.
Trends in Pharmacological Sciences|October 15, 2014
Advances in kinase targeting: current clinical use and clinical trialsMathias Rask-Andersen, Jin Zhang, Doriano Fabbro, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitorsLukasz Skora, Jürgen Mestan, Doriano Fabbro, et al.
Current Pharmaceutical Design|October 8, 2003
SRC family kinases: potential targets for the treatment of human cancer and leukemiaMarkus Warmuth, Robert Damoiseaux, Yi Liu, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Chemical and biological profile of dual Cdk1 and Cdk2 inhibitorsStephan Ruetz, Doriano Fabbro, Juerg Zimmermann, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Chimia|October 29, 2020
Notch Inhibition in Cancer: Challenges and OpportunitiesDoriano Fabbro, Michael Bauer, Maximilien Murone, et al.
Current Opinion in Cell Biology|February 12, 2009
Structural biology contributions to tyrosine kinase drug discoverySandra W Cowan-Jacob, Henrik Möbitz, Doriano Fabbro
British Journal of Pharmacology|January 30, 2015
Ten things you should know about protein kinases: IUPHAR Review 14Doriano Fabbro, Sandra W Cowan-Jacob, Henrik Moebitz
Plos One|July 5, 2012
Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesisNataliya Kotelevets, Doriano Fabbro, Andrea Huwiler, et al.
International Journal of Molecular Sciences|February 25, 2023
Lipids as Targets for Renal Cell Carcinoma TherapyBisera Stepanovska Tanturovska, Roxana Manaila, Doriano Fabbro, et al.
The Journal of Biological Chemistry|October 3, 2002
Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase CRochus Franzen, Doriano Fabbro, Armaz Aschrafi, et al.
Trends in Pharmacological Sciences|October 15, 2014
Advances in kinase targeting: current clinical use and clinical trialsMathias Rask-Andersen, Jin Zhang, Doriano Fabbro, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitorsLukasz Skora, Jürgen Mestan, Doriano Fabbro, et al.
Current Pharmaceutical Design|October 8, 2003
SRC family kinases: potential targets for the treatment of human cancer and leukemiaMarkus Warmuth, Robert Damoiseaux, Yi Liu, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Chemical and biological profile of dual Cdk1 and Cdk2 inhibitorsStephan Ruetz, Doriano Fabbro, Juerg Zimmermann, et al.
Pageof 13